Clinical Trial Update: A Study of PTS100 in Primary HCC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PTS100 in hepatocellular carcinoma (primary liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PTS100

Snippet

Sponsor: Gongwin Biopharm Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN